LILIANA PITU: Open Payments
NPI 1942779475 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,400 in 75 payments from 18 companies in 2025. Trend: 2023 $841 · 2024 $1,234 · 2025 $1,400
Food & beverage: $1,400
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 12 | $277 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $193 |
| Novo Nordisk Inc | 10 | $180 |
| Dexcom, Inc. | 9 | $136 |
| Insulet Corporation | 5 | $92 |
| Xeris Pharmaceuticals, Inc. | 5 | $91 |
| ABBVIE INC. | 3 | $58 |
| CeQur Corporation | 1 | $58 |
| Sequel Med Tech, LLC | 3 | $53 |
| Tandem Diabetes Care, Inc. | 4 | $50 |
Products named: JARDIANCE, MOUNJARO, Dexcom G6 Transmitter, Ozempic, Omnipod, GVOKE HYPOPEN, CeQur Simplicity, TWIIST.
Industry payments across NC — which companies pay providers there.
